Analytical Data
-
Gene name
RHOG
- Application
-
Alternative Names
Rho-related GTP-binding protein RhoG
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P84095
-
Expression Region
1-188aa
-
Molecular Weight
28.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RHOG is a member of the Rho family of small GTPases, which play a critical role in various cellular processes, including cytoskeletal dynamics, cell adhesion, and signal transduction. Over the years, RHOG has garnered significant interest in the scientific community due to its involvement in various physiological and pathological conditions, including cancer metastasis, immune responses, and neurological disorders. The study of RHOG recombinant proteins is essential for understanding its structure-function relationship, regulatory mechanisms, and interactions with downstream effectors. Advances in recombinant DNA technology have facilitated the production of RHOG proteins in appropriate cellular systems, allowing researchers to conduct detailed biochemical and biophysical analyses. These studies not only provide insights into the molecular mechanisms of RHOG action but also have potential therapeutic implications, as targeting RHOG signaling pathways may offer novel strategies for treating diseases associated with its dysregulation. As research progresses, elucidating the role of RHOG in cellular processes will enhance our knowledge of cell biology and may lead to innovative approaches in the field of drug development and disease management.
